Home › Longkanker › Wisconsin › Stevens Point
Longkanker klinische studies in Stevens Point, WI
10 studies voor Longkanker zoeken deelnemers op locaties in en rond Stevens Point (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekruterenFase 3
- Marshfield Medical Center-River Region at Stevens Point, Stevens Point
- Aspirus Cancer Care - Wisconsin Rapids, Wisconsin Rapids · 15 mijl verwijderd
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Aspirus Cancer Care - Stevens Point, Stevens Point
- Aspirus Cancer Care - Wisconsin Rapids, Wisconsin Rapids · 15 mijl verwijderd
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
RekruterenFase 3
- Aspirus Cancer Care - Stevens Point, Stevens Point
- Marshfield Medical Center-River Region at Stevens Point, Stevens Point
- Aspirus Cancer Care - Wisconsin Rapids, Wisconsin Rapids · 15 mijl verwijderd
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
RekruterenFase 3
- Marshfield Medical Center-River Region at Stevens Point, Stevens Point
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RekruterenFase 3
- Aspirus Cancer Care - Stevens Point, Stevens Point
- Marshfield Medical Center-River Region at Stevens Point, Stevens Point
- Aspirus Cancer Care - Wisconsin Rapids, Wisconsin Rapids · 15 mijl verwijderd
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
RekruterenFase 3
- Aspirus Cancer Care - Stevens Point, Stevens Point
- Marshfield Medical Center-River Region at Stevens Point, Stevens Point
- Aspirus Cancer Care - Wisconsin Rapids, Wisconsin Rapids · 15 mijl verwijderd
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekruterenFase 2
- Aspirus Cancer Care - Stevens Point, Stevens Point
- Marshfield Medical Center-River Region at Stevens Point, Stevens Point
- Aspirus Cancer Care - Wisconsin Rapids, Wisconsin Rapids · 15 mijl verwijderd
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RekruterenFase 2
- Marshfield Medical Center-River Region at Stevens Point, Stevens Point
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RekruterenFase 2/3
- Marshfield Medical Center-River Region at Stevens Point, Stevens Point
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
RekruterenObservatieonderzoek
- Marshfield Medical Center-River Region at Stevens Point, Stevens Point
Longkanker studies in andere steden
- Houston, TX78 studies
- Boston, MA62 studies
- New York City, NY60 studies
- Los Angeles, CA45 studies
- Washington, DC41 studies
- Arlington, VA41 studies
- Chicago, IL41 studies
- Nashville, TN40 studies
- Baltimore, MD40 studies
- St. Louis, MO39 studies
- Columbus, OH37 studies
- Philadelphia, PA36 studies
Andere studies in Stevens Point
- Niet-kleincellige longkanker8 studies
- Prostaatkanker7 studies
- Plaveiselcelcarcinoom van hoofd en hals7 studies
- Acute myeloïde leukemie6 studies
- Colorectale kanker5 studies
- Hypopharynxkanker5 studies
- Keelholtekanker5 studies
- Mondkanker5 studies
- Borstkanker5 studies
- Melanoom4 studies
- Nierkanker (niercelcarcinoom)4 studies
- Orofaryngeale kanker3 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.